150 related articles for article (PubMed ID: 10915423)
1. Hepatitis C: limits and dose regimen of interferon alfa.
Prescrire Int; 1998 Oct; 7(37):150-4. PubMed ID: 10915423
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic hepatitis B: interferon alfa first.
Prescrire Int; 2001 Feb; 10(51):17-21. PubMed ID: 11503853
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
Ahmad J; Dodson SF; Demetris AJ; Fung JJ; Shakil AO
Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
[TBL] [Abstract][Full Text] [Related]
4. Chronic hepatitis B: a wider range of therapeutic options.
Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
[TBL] [Abstract][Full Text] [Related]
5. Interferon alfa, peginterferon alfa and retinopathy.
Prescrire Int; 2006 Apr; 15(82):61-2. PubMed ID: 16607695
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
Shakil AO; McGuire B; Crippin J; Teperman L; Demetris AJ; Conjeevaram H; Gish R; Kwo P; Balan V; Wright TL; Brass C; Rakela J
Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
[TBL] [Abstract][Full Text] [Related]
8. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
[TBL] [Abstract][Full Text] [Related]
9. [Compared efficiency of three strategies of management of chronic hepatitis C. Effect on the risk of cirrhosis 8 years after diagnosis].
Michel P; Merle V; Gourier C; Hochain P; Colin R; Czernichow P
Gastroenterol Clin Biol; 1996 Feb; 20(1):47-54. PubMed ID: 8734312
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin: new preparation. An advance, but still no cure-all.
Prescrire Int; 2000 Jun; 9(47):72-5. PubMed ID: 11010742
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of side effects of interferon-alpha in 72 patients treated for chronic active hepatitis C].
Duché A; Decocq G; Capron-Chivrac D; Andréjak M
Therapie; 1995; 50(5):419-23. PubMed ID: 8571279
[TBL] [Abstract][Full Text] [Related]
12. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
Alberti AB; Belli LS; Airoldi A; de Carlis L; Rondinara G; Minola E; Vangeli M; Cernuschi A; D'Amico M; Forti D; Pinzello G
Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up after successful interferon therapy of acute hepatitis C.
Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
[TBL] [Abstract][Full Text] [Related]
14. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
[TBL] [Abstract][Full Text] [Related]
15. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with hepatitis C and cirrhosis.
Wright TL
Hepatology; 2002 Nov; 36(5 Suppl 1):S185-94. PubMed ID: 12407593
[TBL] [Abstract][Full Text] [Related]
17. Management of hepatitis C.
NIH Consens Statement; 1997 Mar 24-26; 15(3):1-41. PubMed ID: 9457159
[TBL] [Abstract][Full Text] [Related]
18. The clinical application of the interferons: a review. NSW Therapeutic Assessment Group.
Stuart-Harris RC; Lauchlan R; Day R
Med J Aust; 1992 Jun; 156(12):869-72. PubMed ID: 1376397
[TBL] [Abstract][Full Text] [Related]
19. Managing patients with hepatitis C.
Drug Ther Bull; 1993 Aug; 31(16):61-2. PubMed ID: 8375275
[No Abstract] [Full Text] [Related]
20. Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b.
Molloy PJ; Azzouz M; Van Thiel DH
Am Fam Physician; 1996 Oct; 54(5):1598-605. PubMed ID: 8857782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
